Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8077624rdf:typepubmed:Citationlld:pubmed
pubmed-article:8077624lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:8077624lifeskim:mentionsumls-concept:C0027126lld:lifeskim
pubmed-article:8077624lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:8077624lifeskim:mentionsumls-concept:C0151721lld:lifeskim
pubmed-article:8077624lifeskim:mentionsumls-concept:C0205174lld:lifeskim
pubmed-article:8077624lifeskim:mentionsumls-concept:C0445223lld:lifeskim
pubmed-article:8077624lifeskim:mentionsumls-concept:C0179630lld:lifeskim
pubmed-article:8077624lifeskim:mentionsumls-concept:C1705968lld:lifeskim
pubmed-article:8077624lifeskim:mentionsumls-concept:C1552599lld:lifeskim
pubmed-article:8077624lifeskim:mentionsumls-concept:C1704787lld:lifeskim
pubmed-article:8077624pubmed:issue5lld:pubmed
pubmed-article:8077624pubmed:dateCreated1994-10-5lld:pubmed
pubmed-article:8077624pubmed:abstractTextThe Authors considered the relationship between hypogonadism in myotonic dystrophy (MD) and MT-PK gene mutation. Twenty-seven subjects were studied, and the (CTG)n amplification varied from 70 to 1520 (mean 661 +/- 463). Hypergonadotropic-hypogonadism with LH levels of 6.94 +/- 3.87 and FSH 14.54 +/- 9.58 IU/L was present; testosterone still showed normal values (505.7 +/- 376.2 ng/dl), but 44.4% of patients had abnormal serum level less than 250 ng/dl. We found a significant correlation (p < 0.001) between CTG repeat size and levels of both LH and FSH: these findings suggest that the severity of hypogonadism is related to MT-PK gene mutation.lld:pubmed
pubmed-article:8077624pubmed:languageenglld:pubmed
pubmed-article:8077624pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8077624pubmed:citationSubsetIMlld:pubmed
pubmed-article:8077624pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8077624pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8077624pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8077624pubmed:statusMEDLINElld:pubmed
pubmed-article:8077624pubmed:monthMaylld:pubmed
pubmed-article:8077624pubmed:issn0391-4097lld:pubmed
pubmed-article:8077624pubmed:authorpubmed-author:NovelloAAlld:pubmed
pubmed-article:8077624pubmed:authorpubmed-author:DallapiccolaB...lld:pubmed
pubmed-article:8077624pubmed:authorpubmed-author:AngeliniCClld:pubmed
pubmed-article:8077624pubmed:authorpubmed-author:BonanniGGlld:pubmed
pubmed-article:8077624pubmed:authorpubmed-author:Mastrogiacomo...lld:pubmed
pubmed-article:8077624pubmed:authorpubmed-author:PaganiEElld:pubmed
pubmed-article:8077624pubmed:authorpubmed-author:GennarelliMMlld:pubmed
pubmed-article:8077624pubmed:authorpubmed-author:MenegazzoEElld:pubmed
pubmed-article:8077624pubmed:issnTypePrintlld:pubmed
pubmed-article:8077624pubmed:volume17lld:pubmed
pubmed-article:8077624pubmed:ownerNLMlld:pubmed
pubmed-article:8077624pubmed:authorsCompleteYlld:pubmed
pubmed-article:8077624pubmed:pagination381-3lld:pubmed
pubmed-article:8077624pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:8077624pubmed:meshHeadingpubmed-meshheading:8077624-...lld:pubmed
pubmed-article:8077624pubmed:meshHeadingpubmed-meshheading:8077624-...lld:pubmed
pubmed-article:8077624pubmed:meshHeadingpubmed-meshheading:8077624-...lld:pubmed
pubmed-article:8077624pubmed:meshHeadingpubmed-meshheading:8077624-...lld:pubmed
pubmed-article:8077624pubmed:meshHeadingpubmed-meshheading:8077624-...lld:pubmed
pubmed-article:8077624pubmed:meshHeadingpubmed-meshheading:8077624-...lld:pubmed
pubmed-article:8077624pubmed:meshHeadingpubmed-meshheading:8077624-...lld:pubmed
pubmed-article:8077624pubmed:meshHeadingpubmed-meshheading:8077624-...lld:pubmed
pubmed-article:8077624pubmed:meshHeadingpubmed-meshheading:8077624-...lld:pubmed
pubmed-article:8077624pubmed:meshHeadingpubmed-meshheading:8077624-...lld:pubmed
pubmed-article:8077624pubmed:meshHeadingpubmed-meshheading:8077624-...lld:pubmed
pubmed-article:8077624pubmed:meshHeadingpubmed-meshheading:8077624-...lld:pubmed
pubmed-article:8077624pubmed:year1994lld:pubmed
pubmed-article:8077624pubmed:articleTitleMale hypogonadism in myotonic dystrophy is related to (CTG)n triplet mutation.lld:pubmed
pubmed-article:8077624pubmed:affiliationIstituto di Semeiotica Medica, University of Padua, Italy.lld:pubmed
pubmed-article:8077624pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8077624pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed